Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study
Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Qualitative Study: Utilization of an Adherence Application
University of Miami
25 participants
Oct 2, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to learn about the experiences of cancer patients during treatment utilizing a mobile app called EveryDose© to track prescribed oral treatment for cancer. Based on these experiences, the study team will decide on expanding this pilot study to evaluate other methods that may prove to be beneficial in supporting cancer patient's ability to take cancer medications as prescribed (another common phrase used for this is adherence to treatment).
Eligibility
Inclusion Criteria5
- Any sex/gender Able to provide written informed consent
- Able to read/understand English or Spanish
- Diagnosis of hematologic or solid tumor cancer diagnosis
- Prescribed an oral anti-cancer drug as monotherapy treatment for the first time by their treating oncologist.
- Internet access on a smartphone, tablet, or computer
Exclusion Criteria6
- Less than 18 years of age
- Unable to provide written informed consent
- Unable to read/understand English or Spanish
- History of dementia or major psychiatric disease that would interfere with study participation
- Prior treatment with an oral anti-cancer treatment
- Participating in another clinical trial during the time of screening.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will use this application every day for up to 10 minutes, for up to 12 weeks. The purpose of the application is to improve medication adherence. Participants will receive an alert to the mobile device while at home to ensure medication was taken, and to serve as a medication log.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06952790